Clinical Trial Update: Stop Air Leak by Talc or Autologous Blood Patch Therapy [Phase 2, Phase 3]

View source ↗

Summary

A trial evaluating talc pleurodesis or autologous blood patch therapy to stop air leaks in spontaneous secondary pneumothorax is in Phase 2 and Phase 3, but it …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spontaneous Pneumothorax

Drugs mentioned

• Autologous blood patch therapy (autologous blood patch)
• Talc pleurodesis (talc)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Pneumothorax Spontaneous Secondary | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING